Sonoma Pharmaceuticals Statistics
NASDAQ: SNOAHealthcareDrug Manufacturers - Specialty & GenericUSD
1.16-0.06 (-4.92%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Sonoma Pharmaceuticals by the numbers
Sonoma Pharmaceuticals has a market capitalization of $5.6 million based on 4.79M shares outstanding. With trailing EPS of $-1.22, Sonoma Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.3% below its 50-day average and 39.0% below its 200-day average.
Average daily trading volume is 107.65K shares, or about $124,875 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SNOA valuation vs. peer median
| Metric | SNOA | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.55M | $4.92M | +13% |
| Avg. volume | 107.65K | 1.70M | -94% |
Peer median across 8 companies: GELS, RDHL, AKAN, YCBD, INM, PRFX, IMCC, APUS.
Valuation
- Market cap
- $5.55M
- EPS (TTM)
- $-1.22
- Shares outstanding
- 4.79M
Price and trading
- Previous close
- 1.22
- Open
- 1.20
- Day range
- 1.14 – 1.20
- 52-week range
- 0.85 – 4.30
- Beta
- —
- Volume
- 88.62K
- Average volume
- 107.65K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 5.55M
- Forward Pe
- -2.07
- Eps
- -1.22
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.30
- Week52 Low
- 0.85
- Avg Volume
- 107.65K
- Shares Outstanding
- 4.79M
- Ma50
- 1.28
- Ma200
- 1.90
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -73.02%
- Pct From52w Low
- 36.47%